دکتر سید آیدین ساجدی : ِDr Seyed Aidin Sajedi

Dr Seyed Aidin Sajedi

۱. Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, et al. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial. Clinical neuropharmacology. ۲۰۱۱;۳۴(۴):۱۷۴-۷
۲. Shahripour RB, Mohammadianinejad SE, Sajedi SA, Tarahhomi S. Report of a Known Case of Rheumatoid Arthritis and Cerebral Vasculitis with a Proper Response to Corticosteroid and Cyclophosphamide Pulse Therapy. Journal of Isfahan Medical School. ۲۰۱۱;۲۹(۱۲۹); ۱۸۸-۱۹۵
۳. Shahripour RB, Shamsaei G, Pakdaman H, Majdinasab N, Nejad EM, Sajedi SA, et al. The effect of NeuroAiD™(MLC۶۰۱) on cerebral blood flow velocity in subjects&#۳۹; post brain infarct in the middle cerebral artery territory. European journal of internal medicine. ۲۰۱۱;۲۲(۵):۵۰۹-۱۳
۴. Sajedi SA, Abdollahi F. Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of ۱۱۱ locations in ۲۴ countries. BMC neurology. ۲۰۱۲;۱۲(۱):۱
۵. Azarpazhooh MR, Shahripour RB, Kapral MK, Mokhber N, Shoeibi A, Farzadfard MT, Rafati MR, Thrift AG, Morovatdar N, Sajedi SA, Azarpazhooh A. Incidence of first ever stroke during Hajj ceremony. BMC neurology. ۲۰۱۳;۱۳(۱):۱
۶. Abdollahi F, Sajedi SA. Correlation of multiple sclerosis (MS) incidence trends with solar and geomagnetic indices: Time to revise the method of reporting MS epidemiological data. Iranian journal of neurology. ۲۰۱۴;۱۳(۲):۶۴-۶۹
۷. Mohammadianinejad SE, Majdinasab N, Sajedi SA, Abdollahi F, Moqaddam MM, Sadr F. The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial. Clinical neuropharmacology. ۲۰۱۴;۳۷(۳):۷۳-۸
۸. Shahripour RB, Mortazavi MM, Barlinn K, Keikhaei B, Mousakhani H, Azarpazhooh MR, Oghbaee M, Sajedi SA, Kepplinger J, Tubbs RS, Albright KC, Alexandrov AV. Can STOP Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell Disease? Journal of stroke. ۲۰۱۴;۱۶(۲):۹۷-۱۰۱
۹. Sajedi SA, Abdollahi F. Geomagnetic disturbance: A new field in multiple sclerosis research. Clinical Neurology and Neurosurgery. ۲۰۱۶: ۱۵۱; ۱۴۲
۱۰. Sajedi SA, Abdollahi F. Multiple Sclerosis and Geomagnetic Disturbances: Investigating a Potentially Important Environmental Risk Factor. In: Ibaraki M, Mori H, editors. Progress in Medical Geology.​ Cambridge Scholars Publishing; Newcastle. ۲۰۱۷ 
۱۱. Sajedi SA, Abdollahi F. Which Environmental Factor Is Correlated with Long-Term Multiple Sclerosis Incidence Trends: Ultraviolet B Radiation or Geomagnetic Disturbances? Multiple Sclerosis International. ۲۰۱۷: ۱-۱۱
۱۲. Iaffaldano P, Simone M, G Lucisano G,
 (...), 
Sajedi SA, (...), McCombefrom P, Grand&#۳۹;Maison F. Prognostic indicators in pediatric clinically isolated syndrome. Annals of Neurology. ۲۰۱۷; ۸۱ (۵): ۷۲۹-۷۳۹
۱۳. 
Abdollahi F, Sajedi SA, Majdinasab N, Saghatoleslami M, Rad HS, Ghorbani A, Kiarashi N. Is there an association between brain iron accumulations with blood iron metabolism markers in multiple sclerosis patients?. Multiple Sclerosis International. ۲۰۱۷; ۲۳ (۱): ۱۲-۱۲
۱۴. 
Sajedi SA. Time to consider alternative environmental risk factor rather than ultra violet-B for multiple sclerosis. Multiple Sclerosis and Related Disorders. ۲۰۱۸: ۲۴; ۴۷
۱۵. Signori A, Izquierdo G, Lugaresi A, (...), 
Sajedi SA, (...), Sormani, MP, Trojano M. Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. Multiple Sclerosis Journal. ۲۰۱۸: ۲۴ (۵): ۶۴۲-۶۵۲
۱۶. Hughes J, Jokubaitis V, Lugaresi A, (...), 
Sajedi SA, (...), Quddus, S, Hinson E. Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis. JAMA Neurology. ۲۰۱۸; ۷۵ (۱۱):۱۴۰۷-۱۴۱۵
۱۷. Mohammadianinejad SE, Majidinasab N, Nejati A, Hatamian H, Mehramiri A, Sajedi SA, Hesam S. Tapering Oral Steroid Treatment After IV Methylprednisolone Pulse Therapy in Demyelinating Optic Neuritis. Caspian Journal of Neurological Sciences. ۲۰۱۸; ۴ (۱): ۱-۵

۱۸. Sajedi SAReader response: Incidence of MS has increased markedly over ۶ decades in Denmark particularly with late onset and in women. Neurology.۲۰۱۹; ۹۲ (۸): ۳۹۷

۱۹. Y Zhou, SB Claflin, J Stankovich, (...), SA Sajedi, (...), Bruce V Taylor. Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype. Multiple Sclerosis Journal. ۲۰۱۹
۲۰. 
Shahjouei S, Naderi S, Li J, (...), Sajedi SA, (...), Abedi V, Zand, R. Risk of stroke in hospitalized SARS-CoV-۲ infected patients: A multinational study. Ebiomedicine. ۲۰۲۰; ۵۹: ۱۰۲۹۳۹


دفعات مشاهده: 483 بار   |   دفعات چاپ: 118 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر


کلیه حقوق این وب سایت متعلق به مرکز تحقیقات علوم اعصاب می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2020 All Rights Reserved | olom aasab

Designed & Developed by : Yektaweb